PetVivo raises $2.15M via registered direct offering of 782,675 shares at $2.75

PetVivo Holdings, Inc.

Gross proceeds of $2,152,355 from sale of 782,675 shares at $2.75/share.
Net proceeds ~$2.06M after $25,000 expenses and $63,456 finder fee to Bancroft Capital.
Funds to be used for commercialization of Spryng™, clinical trials, and working capital.
Bancroft Capital introduced investors purchasing 461,500 shares ($1.27M), earning 5% fee.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

PetVivo Holdings, Inc. entered into Finders Fee Agreement with Bancroft Capital, LLC valued at $63,456.25 (effective 2023-03-28).

Action: entry
Counterparty: Bancroft Capital, LLC
Value: $63,456.25
Effective: 2023-03-28

Exact text from the filing

The Company engaged Bancroft, a broker-dealer registered with the SEC and a member of FINRA, pursuant to a finder’s agreement dated March 28, 2023 (“Finders Fee Agreement”) to introduce it to investors.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

PetVivo Holdings, Inc. entered into Purchase Agreement with certain investors valued at $2,152,355 (effective 2023-04-17).

Action: entry
Agreement: equity purchase
Counterparty: certain investors
Value: $2,152,355
Effective: 2023-04-17

Exact text from the filing

PetVivo Holdings, Inc. (the “Company”) entered into certain documents, including a securities purchase agreement dated April 17, 2023 and/or other confirmation of purchase (the “Purchase Agreement”), with certain investors

View on SEC.gov

Browse all material agreements →

PetVivo Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-012724

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.